肾癌与VHL杂志 SCIE

期刊简介预计审稿时间： 4 Weeks

The Journal of Kidney Cancer and VHL is a peer-reviewed online open access journal that focuses on disseminating research findings on kidney cancer and Von Hippel Lindau disease. Renal cell carcinoma, also known as renal cell carcinoma, accounts for approximately 2% of all cancers, and abnormalities in the VHL gene are the main risk factor for the development of renal cell carcinoma. VHL abnormalities can also lead to another rare disease, VHL syndrome, whose incidence rate is estimated to be 1/36000.

This journal aims to become an academic forum for academic exchange, enabling scientists to develop better treatment strategies for these two diseases. The Journal of Kidney Cancer and VHL publishes basic scientific and clinical research articles on all aspects of kidney cancer and VHL, including original articles, reviews, case reports, brief communications, and letters to editors, and is suitable for submission.

《肾癌与VHL杂志》是一本同行评审的在线开放获取期刊，专注于传播肾癌和VHL（Von Hippel-Lindau）疾病的研究成果。肾癌，也称为肾细胞癌，约占所有癌症的2%，而VHL基因的异常是肾癌发展的主要风险因素。VHL异常也会导致另一种罕见病——VHL综合征，其发病率估计为1/36000 。

该期刊旨在成为一个学术交流的学术论坛，使科学家能够为这两种疾病开发更好的治疗策略。《肾癌与VHL杂志》发表关于肾癌和VHL的所有方面的基础科学和临床研究文章，包括原创文章、综述、病例报告、简短通讯和给编辑的信件等类型的文章，适合提交 。

如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。